A curated listing of global health funding opportunities.
About
The following Horizon Europe/EDCTP3 calls are focused on sub-Saharan Africa.
A. Research & Innovation Actions (RIA)
The 2026 Global Health EDCTP3 calls will support four RIA topics focused on tuberculosis, lower respiratory tract infections, HIV and climate-change-driven infectious diseases.
-
HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage: Global collaboration action towards better prevention, treatment and clinical management of HIV co-infections or co-morbidities in sub-Saharan Africa.
-
HORIZON-JU-GH-EDCTP3-2026-01-LRTI-02-two-stage: Global collaboration action for prevention and treatment of Lower Respiratory Tract Infections in sub-Saharan Africa.
-
HORIZON-JU-GH-EDCTP3-2026-01-TB-01-two-stage: Global collaboration action for the development of TB drugs for therapy and chemoprophylaxis in adults and children in sub-Saharan Africa.
-
HORIZON-JU-GH-EDCTP3-2026-02-CH-01-two-stage: Global collaboration action on climate and health in sub-Saharan Africa.
Amount and Deadline
Funding: €5 million – €10 million per project
Deadline: 4 March 2026 (first stage)
Calls are expected to open by mid-January 2026
B. Coordination and support action (CSA) calls
Two CSA calls will support training and capacity development in sub-Saharan Africa:
-
HORIZON-JU-GH-EDCTP3-2026-03-SERP-01: Training and innovation networks for sustained capacity development related to ethics, regulatory, pharmacovigilance, and related digital regulatory platforms.
-
HORIZON-JU-GH-EDCTP3-2026-03-DIGIT-02: Enhancing integrated research and healthcare in sub-Saharan Africa through digital innovation and Artificial Intelligence.
Amount and deadline
Funding: €1.5 million – €2.25 million per project
Deadline: 31 August 2026 (later deadline; single-stage call, forecast)
Eligibility
Country of applicant institution: Albania, Armenia, Bosnia and Herzegovina, Egypt, European Union (EU), Faroe Islands, Georgia, Republic of, Iceland, Israel, Kosovo, Moldova, Republic of, Montenegro, New Zealand, North Macedonia, Norway, Serbia, Switzerland, Tunisia, Turkey, Ukraine, United Kingdom.
About
This fund provides single-step support for developing a new or repurposed medicine, medical device, diagnostic, or other medical product. Projects should focus on a high-risk development step, supported by prior funding, to generate critical data that either de-risks further progression or confirms failure.
criteria
- Award range: £50,000 - £300,000
- Deadline: 11 March 2026, 4pm UK time
- Eligibility: you must be based at a research organisation eligible for Medical Research Council (MRC) funding
Apply for the MRC Gap fund for single-step support for medical product development
About
This scheme supports academic-led translational projects to develop and test novel therapeutics, medical devices, diagnostics, or other interventions. Projects should aim to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or develop research tools that increase the efficiency of intervention development.
Criteria
- Total fund: £11,000,000
- Deadline: 18 March 2026, 4:00pm UK time
- Criteria: employment at a research organisation eligible for MRC funding.
Apply to the MRC: Developmental Pathway Funding scheme